KZR — Kezar Life Sciences Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM
U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Kezar gains on Aurinia buyout deal
Brief: Aurinia Pharmaceuticals To Acquire Kezar Life Sciences For $6.955 In Cash Per Share Plus A Contingent Value Right
NASDAQ RESUMED AT 08:35 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Gyre Therapeutics, Nutrien Ltd, Rapid Micro Biosystems
U.S. STOCKS ON THE MOVE -Natera, Pacira BioSciences, Kezar Life Sciences
Kezar Life Sciences rises as Enodia buys its preclinical assets
Brief: Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition Of Preclinical Assets From Kezar Life Sciences
Kezar Life Sciences posts narrower Q3 net loss, cuts workforce by 70%
Brief: Kezar Life Sciences Q3 Operating Expenses USD 11.715 Million
Brief: Kezar Life Sciences Inc - To Reduce Workforce By 70% - SEC Filing
U.S. RESEARCH ROUNDUP- Citigroup, eBay, Morgan Stanley
Kezar Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
Kezar Life Sciences Inc expected to post a loss of $2.39 a share - Earnings Preview